4-6301977-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The NM_006005.3(WFS1):c.2182G>A(p.Gly728Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,612,700 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain risk allele (★★). Synonymous variant affecting the same amino acid position (i.e. G728G) has been classified as Likely benign.
Frequency
Consequence
NM_006005.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.2182G>A | p.Gly728Ser | missense_variant | 8/8 | ENST00000226760.5 | NP_005996.2 | |
WFS1 | NM_001145853.1 | c.2182G>A | p.Gly728Ser | missense_variant | 8/8 | NP_001139325.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152196Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000404 AC: 10AN: 247384Hom.: 0 AF XY: 0.0000669 AC XY: 9AN XY: 134588
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1460386Hom.: 0 Cov.: 98 AF XY: 0.0000220 AC XY: 16AN XY: 726490
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152314Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74482
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 728 of the WFS1 protein (p.Gly728Ser). This variant is present in population databases (rs202195756, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with WFS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 130750). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on WFS1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 18, 2014 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 15, 2024 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 33879153) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 05, 2014 | The Gly728Ser variant in WFS1 has not been previously reported in individuals wi th hearing loss, but it has been identified in 0.56% (1/178) of Japanese chromos omes by the 1000 Genomes Project (dbSNP rs202195756). Although this variant has been seen in the general population, its frequency is not high enough to rule ou t a pathogenic role. The glycine (Gly) at position 728 is mostly conserved in m ammals and evolutionary distant species; however, one primate (gorilla) carries a serine (Ser) at this position. While this might raise the possibility that a c hange at this position may be tolerated, this occurrence in one species is not s ufficient to make this assumption. Additional computational prediction tools do not provide strong support for or against an impact to the protein. Splicing pre diction tools suggest that this variant may introduce a 3' splice site within th e exon; however, this information is not predictive enough to determine pathogen icity. In summary, the clinical significance of the Gly728Ser variant is uncerta in. - |
Wolfram syndrome 1 Other:1
Uncertain risk allele, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Potent mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy. However no sufficient evidence is found to ascertain the role of this particular variant rs202195756 in Wolfram's syndrome yet. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at